Tuesday, August 25, 2020 1:35:49 PM
1. Prospects of a Premarket Company are estimated regarding potential market share gain
2. Profitability is calculated on earnings before tax and depreciation
3. BO prize is calculated based on 1 + 2 and discounted (X%) and potentially leveraged due to strategic reasons.
Due to figures presented at the SRS by Goldman Sachs Global Investment research the Us Medical Robotics Market has been In 2019 and will grow to in 2025/2030 in Billion §:
# Soft Tissue Robotic Revenue 3,5/8,1/12,2
# Hard Tissue Robotic Revenue 0,3/ 1,1/1,7
# Flexibel Endoluminal Robotic Revenue 0,0/0,9/2,8
If Martha aims for minimum 25% marketshare cumulative revenue soft tissue for the years 2022 to 2028 would be about 15 Billion.
One can estimate that the rest of the world may contribute half the amount in total so we talk about 22 to 25 Billion for soft Tissue.
Lets assume profitability is minimum 30 % we came up with earnings 6 to 7 Billions. In this case I would guess strategic reasons equalize discounting. MDT payed 1,5 Billion for a 0,3 billion market. J&J payed 3,6 Billion for a non existing market.
I wonder what MDT will pay for the biggest market.
Thanks
Facetrain
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM